Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Negative Breast Carcinoma, Triple-Negative Breast Carcinoma

Sex: Female

Ages: 18 Years – N/A

Phase: NA

Enrollment: 40

Sponsor: Ohio State University Comprehensive Cancer Center

Summary

This clinical trial aims to see if patients with triple negative breast cancer can complete a biobehavioral stress reduction program that also addresses health related social needs (e.g., utilities, transportation, etc.). The stress reduction program is over ten weeks and includes stress reduction (e.g., progressive muscle relaxation), coping, problem solving, communication, and social support. Health related social needs will be evaluated at the beginning of the study, and referrals will be made to social work to help address those needs. The study will examine stress as reported by the patients and also use biological markers.

Eligibility Criteria

Inclusion Criteria:Age >=18 yearsUntreated newly diagnosed triple negative breast cancerStages I-IIIExclusion Criteria:PrisonersMaleIdentifying as American Indian, Alaska Native, Asian, Native Hawaiian or Other Pacific IslanderIndividuals not able to speak and understand EnglishKnown personal history of ductal carcinoma in situ (DCIS) or invasive breast cancerStage IV breast cancer

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05677802). StuddyBuddy aggregates publicly available trial information.